{"audit_author": [{"name": "Celie, P.H.N.", "pdbx_ordinal": 1}, {"name": "Toebes, M.", "pdbx_ordinal": 2}, {"name": "Rodenko, B.", "pdbx_ordinal": 3}, {"name": "Ovaa, H.", "pdbx_ordinal": 4}, {"name": "Perrakis, A.", "pdbx_ordinal": 5}, {"name": "Schumacher, T.N.M.", "pdbx_ordinal": 6}], "cell": {"angle_alpha": 90.0, "angle_beta": 90.76, "angle_gamma": 90.0, "length_a": 62.215, "length_b": 82.774, "length_c": 79.655, "zpdb": 4}, "citation": [{"country": "US", "id": "primary", "journal_abbrev": "J.Am.Chem.Soc.", "journal_id_astm": "JACSAT", "journal_id_csd": "0004", "journal_id_issn": "0002-7863", "journal_volume": "131", "page_first": "12298", "pdbx_database_id_doi": "10.1021/JA9037559", "pdbx_database_id_pub_med": 19655750, "rcsb_authors": ["Celie, P.H.N.", "Toebes, M.", "Rodenko, B.", "Ovaa, H.", "Perrakis, A.", "Schumacher, T.N.M."], "rcsb_is_primary": "Y", "rcsb_journal_abbrev": "J Am Chem Soc", "title": "Uv-Induced Ligand Exchange in Mhc Class I Protein Crystals.", "year": 2009}], "diffrn": [{"ambient_temp": 100.0, "crystal_id": "1", "id": "1"}], "diffrn_detector": [{"details": "MIRRORS", "detector": "CCD", "diffrn_id": "1", "pdbx_collection_date": "2007-10-06T00:00:00+0000", "type": "ADSC CCD"}], "diffrn_radiation": [{"diffrn_id": "1", "monochromator": "NI FILTER", "pdbx_diffrn_protocol": "SINGLE WAVELENGTH", "pdbx_monochromatic_or_laue_ml": "M", "pdbx_scattering_type": "x-ray", "wavelength_id": "1"}], "diffrn_source": [{"diffrn_id": "1", "pdbx_synchrotron_beamline": "ID23-1", "pdbx_synchrotron_site": "ESRF", "pdbx_wavelength": "0.97932", "source": "SYNCHROTRON", "type": "ESRF BEAMLINE ID23-1"}], "entry": {"id": "2X4U"}, "exptl": [{"crystals_number": 1, "method": "X-RAY DIFFRACTION"}], "exptl_crystal": [{"density_matthews": 2.29, "density_percent_sol": 42.0, "description": "NONE", "id": "1"}], "exptl_crystal_grow": [{"crystal_id": "1", "pdbx_details": "100 MM MES PH 5.5, 20% PEG 1500. CRYSTALS WERE FROZEN IN 100 MM MES, 30% PEG 1500, 10% GLYCEROL", "ph": 6.5}], "pdbx_audit_revision_category": [{"category": "pdbx_database_status", "data_content_type": "Structure model", "ordinal": 1, "revision_ordinal": 4}, {"category": "reflns_shell", "data_content_type": "Structure model", "ordinal": 2, "revision_ordinal": 4}], "pdbx_audit_revision_details": [{"data_content_type": "Structure model", "ordinal": 1, "provider": "repository", "revision_ordinal": 1, "type": "Initial release"}], "pdbx_audit_revision_group": [{"data_content_type": "Structure model", "group": "Version format compliance", "ordinal": 1, "revision_ordinal": 2}, {"data_content_type": "Structure model", "group": "Version format compliance", "ordinal": 2, "revision_ordinal": 3}, {"data_content_type": "Structure model", "group": "Data collection", "ordinal": 3, "revision_ordinal": 4}, {"data_content_type": "Structure model", "group": "Other", "ordinal": 4, "revision_ordinal": 4}], "pdbx_audit_revision_history": [{"data_content_type": "Structure model", "major_revision": 1, "minor_revision": 0, "ordinal": 1, "revision_date": "2010-03-02T00:00:00+0000"}, {"data_content_type": "Structure model", "major_revision": 1, "minor_revision": 1, "ordinal": 2, "revision_date": "2011-05-07T00:00:00+0000"}, {"data_content_type": "Structure model", "major_revision": 1, "minor_revision": 2, "ordinal": 3, "revision_date": "2011-07-13T00:00:00+0000"}, {"data_content_type": "Structure model", "major_revision": 1, "minor_revision": 3, "ordinal": 4, "revision_date": "2019-10-16T00:00:00+0000"}], "pdbx_audit_revision_item": [{"data_content_type": "Structure model", "item": "_pdbx_database_status.status_code_sf", "ordinal": 1, "revision_ordinal": 4}, {"data_content_type": "Structure model", "item": "_reflns_shell.Rmerge_I_obs", "ordinal": 2, "revision_ordinal": 4}], "pdbx_database_related": [{"content_type": "unspecified", "db_id": "1UQS", "db_name": "PDB", "details": "THE CRYSTAL STRUCTURE OF HUMAN CD1B WITH A BOUND BACTERIAL GLYCOLIPID"}, {"content_type": "unspecified", "db_id": "1BD2", "db_name": "PDB", "details": "COMPLEX BETWEEN HUMAN T-CELL RECEPTOR B7, VIRAL PEPTIDE (TAX) AND MHC CLASS I MOLECULE HLA-A 0201"}, {"content_type": "unspecified", "db_id": "1HPS", "db_name": "PDB", "details": "HIV-1 PROTEASE COMPLEXED WITH SB206343"}, {"content_type": "unspecified", "db_id": "2ESV", "db_name": "PDB", "details": "STRUCTURE OF THE HLA-E-VMAPRTLIL/KK50.4 TCR COMPLEX"}, {"content_type": "unspecified", "db_id": "2AK4", "db_name": "PDB", "details": "CRYSTAL STRUCTURE OF SB27 TCR IN COMPLEX WITH HLA-B*3508-13MER PEPTIDE"}, {"content_type": "unspecified", "db_id": "1T7K", "db_name": "PDB", "details": "CRYSTAL STRUCTURE OF HIV PROTEASE COMPLEXED WITHARYLSULFONAMIDE AZACYCLIC UREA"}, {"content_type": "unspecified", "db_id": "1YPZ", "db_name": "PDB", "details": "IMMUNE RECEPTOR"}, {"content_type": "unspecified", "db_id": "1R0A", "db_name": "PDB", "details": "CRYSTAL STRUCTURE OF HIV-1 REVERSE TRANSCRIPTASE COVALENTLYTETHERED TO DNA TEMPLATE -PRIMER SOLVED TO 2.8 ANGSTROMS"}, {"content_type": "unspecified", "db_id": "1IM3", "db_name": "PDB", "details": "CRYSTAL STRUCTURE OF THE HUMAN CYTOMEGALOVIRUS PROTEIN US2BOUND TO THE MHC CLASS I MOLECULE HLA-A2/TAX"}, {"content_type": "unspecified", "db_id": "1HPZ", "db_name": "PDB", "details": "HUMAN IMMUNODEFICIENCY VIRUS TYPE 1"}, {"content_type": "unspecified", "db_id": "1UXW", "db_name": "PDB", "details": "CRYSTAL STRUCTURE OF HLA-B*2709 COMPLEXED WITH THE LATENT MEMBRANE PROTEIN 2 PEPTIDE (LMP2) OF EPSTEIN-BARR VIRUS"}, {"content_type": "unspecified", "db_id": "1I7U", "db_name": "PDB", "details": "CRYSTAL STRUCTURE OF CLASS I MHC A2 IN COMPLEX WITH PEPTIDEP1049-6V"}, {"content_type": "unspecified", "db_id": "2VG6", "db_name": "PDB", "details": "CRYSTAL STRUCTURES OF HIV-1 REVERSE TRANSCRIPTASE COMPLEXES WITH THIOCARBAMATE NON- NUCLEOSIDE INHIBITORS"}, {"content_type": "unspecified", "db_id": "1QE1", "db_name": "PDB", "details": "CRYSTAL STRUCTURE OF 3TC-RESISTANT M184I MUTANT OF HIV-1 REVERSE TRANSCRIPTASE"}, {"content_type": "unspecified", "db_id": "1NPA", "db_name": "PDB", "details": "CRYSTAL STRUCTURE OF HIV-1 PROTEASE-HUP"}, {"content_type": "unspecified", "db_id": "1C16", "db_name": "PDB", "details": "CRYSTAL STRUCTURE ANALYSIS OF THE GAMMA/ DELTA T CELL LIGAND T22"}, {"content_type": "unspecified", "db_id": "1HSA", "db_name": "PDB", "details": "HUMAN CLASS I HISTOCOMPATIBILITY ANTIGEN HLA- B(ASTERISK)2705"}, {"content_type": "unspecified", "db_id": "1EBK", "db_name": "PDB", "details": "STRUCTURAL AND KINETIC ANALYSIS OF DRUG RESISTANT MUTANTS OF HIV-1 PROTEASE"}, {"content_type": "unspecified", "db_id": "1TVR", "db_name": "PDB", "details": "HIV-1 RT/9-CL TIBO"}, {"content_type": "unspecified", "db_id": "1W5Y", "db_name": "PDB", "details": "HIV-1 PROTEASE IN COMPLEX WITH FLUORO SUBSTITUTED DIOL-BASED C2-SYMMETRIC INHIBITOR"}, {"content_type": "unspecified", "db_id": "1HOS", "db_name": "PDB", "details": "HIV-1 PROTEASE COMPLEX WITH SB204144"}, {"content_type": "unspecified", "db_id": "1GZP", "db_name": "PDB", "details": "CD1B IN COMPLEX WITH GM2 GANGLIOSIDE"}, {"content_type": "unspecified", "db_id": "2AXF", "db_name": "PDB", "details": "THE IMMUNOGENICITY OF A VIRAL CYTOTOXIC T CELL EPITOPE ISCONTROLLED BY ITS MHC-BOUND CONFORMATION"}, {"content_type": "unspecified", "db_id": "2BNQ", "db_name": "PDB", "details": "STRUCTURAL AND KINETIC BASIS FOR HIGHTENED IMMUNOGENICITY OF T CELL VACCINES"}, {"content_type": "unspecified", "db_id": "1IKW", "db_name": "PDB", "details": "WILD TYPE HIV-1 REVERSE TRANSCRIPTASE IN COMPLEX WITHEFAVIRENZ"}, {"content_type": "unspecified", "db_id": "1S6Q", "db_name": "PDB", "details": "CRYSTAL STRUCTURE OF HIV-1 REVERSE TRANSCRIPTASE (RT) INCOMPLEX WITH JANSSEN- R147681"}, {"content_type": "unspecified", "db_id": "3HVT", "db_name": "PDB", "details": "REVERSE TRANSCRIPTASE"}, {"content_type": "unspecified", "db_id": "1EC1", "db_name": "PDB", "details": "HIV-1 PROTEASE IN COMPLEX WITH THE INHIBITOR BEA409"}, {"content_type": "unspecified", "db_id": "1W72", "db_name": "PDB", "details": "CRYSTAL STRUCTURE OF HLA-A1:MAGE-A1 IN COMPLEX WITH FAB-HYB3"}, {"content_type": "unspecified", "db_id": "2JCC", "db_name": "PDB", "details": "AH3 RECOGNITION OF MUTANT HLA-A2 W167A"}, {"content_type": "unspecified", "db_id": "2BCK", "db_name": "PDB", "details": "CRYSTAL STRUCTURE OF HLA-A*2402 COMPLEXED WITH A TELOMERASEPEPTIDE"}, {"content_type": "unspecified", "db_id": "1DE4", "db_name": "PDB", "details": "HEMOCHROMATOSIS PROTEIN HFE COMPLEXED WITH TRANSFERRINRECEPTOR"}, {"content_type": "unspecified", "db_id": "1T05", "db_name": "PDB", "details": "HIV-1 REVERSE TRANSCRIPTASE CROSSLINKED TO TEMPLATE-PRIMERWITH TENOFOVIR-DIPHOSPHATE BOUND AS THE INCOMINGNUCLEOTIDE SUBSTRATE"}, {"content_type": "unspecified", "db_id": "2VLK", "db_name": "PDB", "details": "THE STRUCTURAL DYNAMICS AND ENERGETICS OF AN IMMUNODOMINANT T-CELL RECEPTOR ARE PROGRAMMED BY ITS VBETA DOMAIN"}, {"content_type": "unspecified", "db_id": "1D4I", "db_name": "PDB", "details": "HIV-1 PROTEASE IN COMPLEX WITH THE INHIBITOR BEA425"}, {"content_type": "unspecified", "db_id": "1EXU", "db_name": "PDB", "details": "CRYSTAL STRUCTURE OF THE HUMAN MHC-RELATED FC RECEPTOR"}, {"content_type": "unspecified", "db_id": "1MEU", "db_name": "PDB", "details": "HIV-1 MUTANT (V82F, I84V) PROTEASE COMPLEXED WITH DMP323"}, {"content_type": "unspecified", "db_id": "1QRN", "db_name": "PDB", "details": "CRYSTAL STRUCTURE OF HUMAN A6 TCR COMPLEXED WITH HLA-A2 BOUND TO ALTERED HTLV-1 TAX PEPTIDE P6A"}, {"content_type": "unspecified", "db_id": "2HLA", "db_name": "PDB", "details": "HUMAN CLASS I HISTOCOMPATIBILITY ANTIGEN AW 68.1 (HLA-AW 68.1, HUMAN LEUCOCYTE ANTIGEN)"}, {"content_type": "unspecified", "db_id": "1HNV", "db_name": "PDB", "details": "HIV-1 REVERSE TRANSCRIPTASE (HIV-1 RT) MUTANT WITH CYS 280 REPLACED BY SER (C280S)"}, {"content_type": "unspecified", "db_id": "1RVR", "db_name": "PDB", "details": "REVERSE TRANSCRIPTASE NON-NUCLEOSIDE BINDING SITE COMPLEXED WITH IMIDAZODIPYRIDODIAZEPINE (UK -129,485) (THEORETICAL MODEL)"}, {"content_type": "unspecified", "db_id": "1MHE", "db_name": "PDB", "details": "THE HUMAN NON-CLASSICAL MAJOR HISTOCOMPATIBILITY COMPLEX MOLECULE HLA-E"}, {"content_type": "unspecified", "db_id": "1IM9", "db_name": "PDB", "details": "CRYSTAL STRUCTURE OF THE HUMAN NATURAL KILLER CELLINHIBITORY RECEPTOR KIR2DL1 BOUND TO ITS MHC LIGAND HLA-CW4"}, {"content_type": "unspecified", "db_id": "1EEZ", "db_name": "PDB", "details": "CRYSTAL STRUCTURE DETERMINATION OF HLA-A2.1 COMPLEXED TOGP2 PEPTIDE VARIANT(I2L/V5L)"}, {"content_type": "unspecified", "db_id": "1N6Q", "db_name": "PDB", "details": "HIV-1 REVERSE TRANSCRIPTASE CROSSLINKED TO PRE-TRANSLOCATION AZTMP-TERMINATED DNA ( COMPLEX N)"}, {"content_type": "unspecified", "db_id": "1JHT", "db_name": "PDB", "details": "CRYSTAL STRUCTURE OF HLA-A2*0201 IN COMPLEX WITH ANONAMERIC ALTERED PEPTIDE LIGAND (ALGIGILTV) FROM THE MART-1/MELAN-A."}, {"content_type": "unspecified", "db_id": "1D4H", "db_name": "PDB", "details": "HIV-1 PROTEASE IN COMPLEX WITH THE INHIBITOR BEA435"}, {"content_type": "unspecified", "db_id": "1RVN", "db_name": "PDB", "details": "REVERSE TRANSCRIPTASE NON-NUCLEOSIDE BINDING SITE COMPLEXED WITH PHENYL-ISOINDOLINONE ( THEORETICAL MODEL)"}, {"content_type": "unspecified", "db_id": "1HBV", "db_name": "PDB", "details": "HIV-1 PROTEASE COMPLEXED WITH SB203238"}, {"content_type": "unspecified", "db_id": "1QQD", "db_name": "PDB", "details": "CRYSTAL STRUCTURE OF HLA-CW4, A LIGAND FOR THE KIR2D NATURAL KILLER CELL INHIBITORY RECEPTOR"}, {"content_type": "unspecified", "db_id": "1QR1", "db_name": "PDB", "details": "POOR BINDING OF A HER-2/NEU EPITOPE (GP2 ) TO HLA-A2.1 IS DUE TO A LACK OF INTERACTIONS IN THE CENTER OF THE PEPTIDE"}, {"content_type": "unspecified", "db_id": "1HTF", "db_name": "PDB", "details": "HIV-1 PROTEASE COMPLEXED WITH GR126045"}, {"content_type": "unspecified", "db_id": "1RTD", "db_name": "PDB", "details": "STRUCTURE OF A CATALYTIC COMPLEX OF HIV-1 REVERSE TRANSCRIPTASE: IMPLICATIONS FOR NUCLEOSIDE ANALOG DRUG RESISTANCE"}, {"content_type": "unspecified", "db_id": "1ZS8", "db_name": "PDB", "details": "CRYSTAL STRUCTURE OF THE MURINE MHC CLASS IB MOLECULE M10.5"}, {"content_type": "unspecified", "db_id": "1HLA", "db_name": "PDB", "details": "HUMAN CLASS I HISTOCOMPATIBILITY ANTIGEN A2 ( HLA-A2, HUMAN LEUCOCYTE ANTIGEN)"}, {"content_type": "unspecified", "db_id": "1JGD", "db_name": "PDB", "details": "HLA-B*2709 BOUND TO DECA-PEPTIDE S10R"}, {"content_type": "unspecified", "db_id": "1I1Y", "db_name": "PDB", "details": "CRYSTAL STRUCTURE OF HUMAN CLASS I MHC ( HLA-A2.1) COMPLEXED WITH BETA 2- MICROGLOBULIN AND HIV-RT VARIANT PEPTIDE I1Y"}, {"content_type": "unspecified", "db_id": "2HMI", "db_name": "PDB", "details": "HIV-1 REVERSE TRANSCRIPTASE COMPLEXED WITH A DOUBLE-STRANDED DEOXYRIBONUCLEIC ACID AND FAB28"}, {"content_type": "unspecified", "db_id": "1W5V", "db_name": "PDB", "details": "HIV-1 PROTEASE IN COMPLEX WITH FLUORO SUBSTITUTED DIOL-BASED C2-SYMMETRIC INHIBITOR"}, {"content_type": "unspecified", "db_id": "1VGK", "db_name": "PDB", "details": "THE CRYSTAL STRUCTURE OF CLASS I MAJOR HISTOCOMPATIBILITYCOMPLEX, H-2KD AT 2.0 A RESOLUTION"}, {"content_type": "unspecified", "db_id": "1AGE", "db_name": "PDB", "details": "ANTAGONIST HIV-1 GAG PEPTIDES INDUCE STRUCTURAL CHANGES IN HLA B8 - HIV-1 GAG PEPTIDE (GGKKKYRL - 7R MUTATION)"}, {"content_type": "unspecified", "db_id": "1UR7", "db_name": "PDB", "details": "MOLECULAR REFINEMENT OF ANTI-HLA-A2 USING LIGHT CHAIN SHUFFLING: A STRUCTURAL MODEL FOR HLA ANTIBODY BINDING"}, {"content_type": "unspecified", "db_id": "2BBB", "db_name": "PDB", "details": "STRUCTURE OF HIV1 PROTEASE AND HH1_173_3A COMPLEX."}, {"content_type": "unspecified", "db_id": "1HHG", "db_name": "PDB"}, {"content_type": "unspecified", "db_id": "1S9X", "db_name": "PDB", "details": "CRYSTAL STRUCTURE ANALYSIS OF NY-ESO-1 EPITOPE ANALOGUE,SLLMWITQA, IN COMPLEX WITH HLA-A2"}, {"content_type": "unspecified", "db_id": "1A9E", "db_name": "PDB", "details": "DECAMER-LIKE CONFORMATION OF A NANO-PEPTIDE BOUND TO HLA-B 3501 DUE TO NONSTANDARD POSITIONING OF THE C-TERMINUS"}, {"content_type": "unspecified", "db_id": "1DUZ", "db_name": "PDB", "details": "HUMAN CLASS I HISTOCOMPATIBILITY ANTIGEN (HLA -A 0201) INCOMPLEX WITH A NONAMERIC PEPTIDE FROM HTLV-1 TAX PROTEIN"}, {"content_type": "unspecified", "db_id": "2CLR", "db_name": "PDB", "details": "HUMAN CLASS I HISTOCOMPATIBILITY ANTIGEN (HLA -A 0201) COMPLEXED WITH A DECAMERIC PEPTIDE FROM CALRETICULIN"}, {"content_type": "unspecified", "db_id": "3HLA", "db_name": "PDB", "details": "HUMAN CLASS I HISTOCOMPATIBILITY ANTIGEN A2. 1 (HLA-A2.1 HUMAN LEUCOCYTE ANTIGEN)"}, {"content_type": "unspecified", "db_id": "1M05", "db_name": "PDB", "details": "HLA B8 IN COMPLEX WITH AN EPSTEIN BARR VIRUS DETERMINANT"}, {"content_type": "unspecified", "db_id": "1DLO", "db_name": "PDB", "details": "HUMAN IMMUNODEFICIENCY VIRUS TYPE 1"}, {"content_type": "unspecified", "db_id": "1HEG", "db_name": "PDB", "details": "HIV-1 PROTEASE COMPLEXED WITH SKF 107457 ( HEG)"}, {"content_type": "unspecified", "db_id": "1TVB", "db_name": "PDB", "details": "CRYSTAL STRUCTURE OF MELANOMA ANTIGEN GP100( 209-217) BOUNDTO HUMAN CLASS I MHC HLA- A2"}, {"content_type": "unspecified", "db_id": "1RVL", "db_name": "PDB", "details": "REVERSE TRANSCRIPTASE NON-NUCLEOSIDE BINDING SITE COMPLEXED WITH ALPHA-APA (R89439) ( THEORETICAL MODEL)"}, {"content_type": "unspecified", "db_id": "2V2W", "db_name": "PDB", "details": "T CELL CROSS-REACTIVITY AND CONFORMATIONAL CHANGES DURING TCR ENGAGEMENT"}, {"content_type": "unspecified", "db_id": "1DW6", "db_name": "PDB", "details": "STRUCTURAL AND KINETIC ANALYSIS OF DRUG RESISTANT MUTANTS OF HIV-1 PROTEASE"}, {"content_type": "unspecified", "db_id": "2VLR", "db_name": "PDB", "details": "THE STRUCTURAL DYNAMICS AND ENERGETICS OF AN IMMUNODOMINANT T-CELL RECEPTOR ARE PROGRAMMED BY ITS VBETA DOMAIN"}, {"content_type": "unspecified", "db_id": "1ONQ", "db_name": "PDB", "details": "CRYSTAL STRUCTURE OF CD1A IN COMPLEX WITH A SULFATIDE"}, {"content_type": "unspecified", "db_id": "1YT9", "db_name": "PDB", "details": "HIV PROTEASE WITH OXIMINOARYLSULFONAMIDE BOUND"}, {"content_type": "unspecified", "db_id": "1A1N", "db_name": "PDB", "details": "MHC CLASS I MOLECULE B*3501 COMPLEXED WITH PEPTIDE VPLRPMTYFROM THE NEF PROTEIN (75- 82) OF HIV1"}, {"content_type": "unspecified", "db_id": "2BVO", "db_name": "PDB", "details": "STRUCTURES OF THREE HIV-1 HLA-B5703- PEPTIDE COMPLEXES AND IDENTIFICATION OF RELATED HLAS POTENTIALLY ASSOCIATED WITH LONG -TERM NON-PROGRESSION"}, {"content_type": "unspecified", "db_id": "1HTG", "db_name": "PDB", "details": "HIV-1 PROTEASE COMPLEXED WITH GR137615"}, {"content_type": "unspecified", "db_id": "1LP9", "db_name": "PDB", "details": "XENOREACTIVE COMPLEX AHIII 12.2 TCR BOUND TO P1049/HLA-A2.1"}, {"content_type": "unspecified", "db_id": "1ZSD", "db_name": "PDB", "details": "CRYSTAL STRUCTURE OF HLA-B*3501 PRESENTING AN 11-MER EBVANTIGEN EPLPQGQLTAY"}, {"content_type": "unspecified", "db_id": "1M6O", "db_name": "PDB", "details": "CRYSTAL STRUCTURE OF HLA B*4402 IN COMPLEX WITH HLADPA*0201 PEPTIDE"}, {"content_type": "unspecified", "db_id": "2BAN", "db_name": "PDB", "details": "CRYSTAL STRUCTURE OF HIV-1 REVERSE TRANSCRIPTASE (RT) INCOMPLEX WITH JANSSEN- R157208"}, {"content_type": "unspecified", "db_id": "1RDH", "db_name": "PDB", "details": "HIV-1 REVERSE TRANSCRIPTASE (RIBONUCLEASE H DOMAIN)"}, {"content_type": "unspecified", "db_id": "1HHK", "db_name": "PDB"}, {"content_type": "unspecified", "db_id": "1HSB", "db_name": "PDB", "details": "CLASS I HISTOCOMPATIBILITY ANTIGEN AW68.1 ( LEUCOCYTE ANTIGEN)"}, {"content_type": "unspecified", "db_id": "1ZT4", "db_name": "PDB", "details": "THE CRYSTAL STRUCTURE OF HUMAN CD1D WITH AND WITHOUT ALPHA-GALACTOSYLCERAMIDE"}, {"content_type": "unspecified", "db_id": "1X7Q", "db_name": "PDB", "details": "CRYSTAL STRUCTURE OF HLA-A*1101 WITH SARS NUCLEOCAPSIDPEPTIDE"}, {"content_type": "unspecified", "db_id": "1CE6", "db_name": "PDB", "details": "MHC CLASS I H-2DB COMPLEXED WITH A SENDAI VIRUSNUCLEOPROTEIN PEPTIDE"}, {"content_type": "unspecified", "db_id": "1RVO", "db_name": "PDB", "details": "REVERSE TRANSCRIPTASE NON-NUCLEOSIDE BINDING SITE COMPLEXED WITH NEVIRAPINE (THEORETICAL MODEL)"}, {"content_type": "unspecified", "db_id": "1PY4", "db_name": "PDB", "details": "BETA2 MICROGLOBULIN MUTANT H31Y DISPLAYS HINTS FOR AMYLOIDFORMATIONS"}, {"content_type": "unspecified", "db_id": "1SYV", "db_name": "PDB", "details": "HLA-B*4405 COMPLEXED TO THE DOMINANT SELF LIGAND EEFGRAYGF"}, {"content_type": "unspecified", "db_id": "2J8U", "db_name": "PDB", "details": "LARGE CDR3A LOOP ALTERATION AS A FUNCTION OF MHC MUTATION."}, {"content_type": "unspecified", "db_id": "1SYS", "db_name": "PDB", "details": "CRYSTAL STRUCTURE OF HLA, B*4403, AND PEPTIDE EEPTVIKKY"}, {"content_type": "unspecified", "db_id": "1HIH", "db_name": "PDB", "details": "HIV-1 PROTEASE COMPLEXED WITH INHIBITOR CGP 53820"}, {"content_type": "unspecified", "db_id": "1HEF", "db_name": "PDB", "details": "HIV-1 PROTEASE COMPLEXED WITH SKF 108738 ( HEF)"}, {"content_type": "unspecified", "db_id": "1HNI", "db_name": "PDB", "details": "HUMAN IMMUNODEFICIENCY VIRUS TYPE 1 REVERSE TRANSCRIPTASE (HIV-1RT) MUTANT WITH CYS 280 REPLACED BY SER (C280S)"}, {"content_type": "unspecified", "db_id": "1TV6", "db_name": "PDB", "details": "HIV-1 REVERSE TRANSCRIPTASE COMPLEXED WITH CP-94,707"}, {"content_type": "unspecified", "db_id": "1OGT", "db_name": "PDB", "details": "CRYSTAL STRUCTURE OF HLA-B*2709 COMPLEXED WITH THE VASOACTIVE INTESTINAL PEPTIDE TYPE 1 RECEPTOR (VPAC1) PEPTIDE (RESIDUES 400-408 )"}, {"content_type": "unspecified", "db_id": "1A9M", "db_name": "PDB", "details": "G48H MUTANT OF HIV-1 PROTEASE IN COMPLEX WITH A PEPTIDIC INHIBITOR U-89360E"}, {"content_type": "unspecified", "db_id": "1CG9", "db_name": "PDB", "details": "COMPLEX RECOGNITION OF THE SUPERTYPIC BW6- DETERMINANT ONHLA-B AND-C MOLECULES BY THE MONOCLONAL ANTIBODY SFR8-B6"}, {"content_type": "unspecified", "db_id": "1P7Q", "db_name": "PDB", "details": "CRYSTAL STRUCTURE OF HLA-A2 BOUND TO LIR- 1, A HOST ANDVIRAL MHC RECEPTOR"}, {"content_type": "unspecified", "db_id": "1EBZ", "db_name": "PDB", "details": "HIV-1 PROTEASE IN COMPLEX WITH THE INHIBITOR BEA388"}, {"content_type": "unspecified", "db_id": "2B5J", "db_name": "PDB", "details": "CRYSTAL STRUCTURE OF HIV-1 REVERSE TRANSCRIPTASE (RT) INCOMPLEX WITH JANSSEN- R165481"}, {"content_type": "unspecified", "db_id": "1MET", "db_name": "PDB", "details": "HIV-1 MUTANT (V82F) PROTEASE COMPLEXED WITH DMP323"}, {"content_type": "unspecified", "db_id": "1HYS", "db_name": "PDB", "details": "CRYSTAL STRUCTURE OF HIV-1 REVERSE TRANSCRIPTASE IN COMPLEXWITH A POLYPURINE TRACT RNA:DNA"}, {"content_type": "unspecified", "db_id": "1T03", "db_name": "PDB", "details": "HIV-1 REVERSE TRANSCRIPTASE CROSSLINKED TO TENOFOVIRTERMINATED TEMPLATE-PRIMER (COMPLEX P)"}, {"content_type": "unspecified", "db_id": "1Q94", "db_name": "PDB", "details": "STRUCTURES OF HLA-A*1101 IN COMPLEX WITH IMMUNODOMINANTNONAMER AND DECAMER HIV-1 EPITOPES CLEARLY REVEAL THEPRESENCE OF A MIDDLE ANCHOR RESIDUE"}, {"content_type": "unspecified", "db_id": "1AXA", "db_name": "PDB", "details": "ACTIVE-SITE MOBILITY IN HUMAN IMMUNODEFICIENCY VIRUS TYPE 1 PROTEASE AS DEMONSTRATED BY CRYSTAL STRUCTURE OF A28S MUTANT"}, {"content_type": "unspecified", "db_id": "1JNJ", "db_name": "PDB", "details": "NMR SOLUTION STRUCTURE OF THE HUMAN BETA2- MICROGLOBULIN"}, {"content_type": "unspecified", "db_id": "1MER", "db_name": "PDB", "details": "HIV-1 MUTANT (I84V) PROTEASE COMPLEXED WITH DMP450"}, {"content_type": "unspecified", "db_id": "1NPW", "db_name": "PDB", "details": "CRYSTAL STRUCTURE OF HIV PROTEASE COMPLEXED WITH LGZ479"}, {"content_type": "unspecified", "db_id": "1AGB", "db_name": "PDB", "details": "ANTAGONIST HIV-1 GAG PEPTIDES INDUCE STRUCTURAL CHANGES IN HLA B8 - HIV-1 GAG PEPTIDE (GGRKKYKL - 3R MUTATION)"}, {"content_type": "unspecified", "db_id": "3TLH", "db_name": "PDB", "details": "STRUCTURAL STUDIES OF HIV AND FIV PROTEASES COMPLEXED WITHAN EFFICIENT INHIBITOR OF FIV PR"}, {"content_type": "unspecified", "db_id": "2D31", "db_name": "PDB", "details": "CRYSTAL STRUCTURE OF DISULFIDE-LINKED HLA-G DIMER"}, {"content_type": "unspecified", "db_id": "1SUQ", "db_name": "PDB", "details": "CRYSTAL STRUCTURE OF HIV-1 REVERSE TRANSCRIPTASE (RT) INCOMPLEX WITH JANSSEN- R185545"}, {"content_type": "unspecified", "db_id": "2UXZ", "db_name": "PDB", "details": "TWO-CARBON-ELONGATED HIV-1 PROTEASE INHIBITORS WITH A TERTIARY-ALCOHOL-CONTAINING TRANSITION-STATE MIMIC"}, {"content_type": "unspecified", "db_id": "1HVK", "db_name": "PDB", "details": "HIV-1 PROTEASE COMPLEXED WITH THE INHIBITOR A76928 (S,S)"}, {"content_type": "unspecified", "db_id": "1SBG", "db_name": "PDB", "details": "HIV-1 PROTEASE COMPLEXED WITH THE INHIBITOR SB203386"}, {"content_type": "unspecified", "db_id": "1AQD", "db_name": "PDB", "details": "HLA-DR1 (DRA, DRB1 0101) HUMAN CLASS II HISTOCOMPATIBILITYPROTEIN (EXTRACELLULAR DOMAIN) COMPLEXED WITH ENDOGENOUSPEPTIDE"}, {"content_type": "unspecified", "db_id": "1UWB", "db_name": "PDB", "details": "TYR 181 CYS HIV-1 RT/8-CL TIBO"}, {"content_type": "unspecified", "db_id": "1XZ0", "db_name": "PDB", "details": "CRYSTAL STRUCTURE OF CD1A IN COMPLEX WITH A SYNTHETICMYCOBACTIN LIPOPEPTIDE"}, {"content_type": "unspecified", "db_id": "1LDS", "db_name": "PDB", "details": "CRYSTAL STRUCTURE OF MONOMERIC HUMAN BETA-2 -MICROGLOBULIN"}, {"content_type": "unspecified", "db_id": "1HTE", "db_name": "PDB", "details": "HIV-1 PROTEASE COMPLEXED WITH GR123976"}, {"content_type": "unspecified", "db_id": "1TVH", "db_name": "PDB", "details": "CRYSTAL STRUCTURE OF MODIFIED MELANOMA ANTIGEN GP100(209-T2M) BOUND TO HUMAN CLASS I MHC HLA-A2"}, {"content_type": "unspecified", "db_id": "1HHH", "db_name": "PDB"}, {"content_type": "unspecified", "db_id": "1HRH", "db_name": "PDB", "details": "RIBONUCLEASE H DOMAIN OF HIV-1 REVERSE TRANSCRIPTASE"}, {"content_type": "unspecified", "db_id": "1XR8", "db_name": "PDB", "details": "CRYSTAL STRUCTURES OF HLA-B*1501 IN COMPLEX WITH PEPTIDESFROM HUMAN UBCH6 AND EPSTEIN-BARR VIRUS EBNA-3"}, {"content_type": "unspecified", "db_id": "1HQU", "db_name": "PDB", "details": "HUMAN IMMUNODEFICIENCY VIRUS TYPE 1"}, {"content_type": "unspecified", "db_id": "2BSS", "db_name": "PDB", "details": "CRYSTAL STRUCTURES AND KIR3DL1 RECOGNITION OF THREE IMMUNODOMINANT VIRAL PEPTIDES COMPLEXED TO HLA-B2705"}, {"content_type": "unspecified", "db_id": "1A1M", "db_name": "PDB", "details": "MHC CLASS I MOLECULE B*5301 COMPLEXED WITH PEPTIDETYPDINQML FROM GAG PROTEIN OF HIV2"}, {"content_type": "unspecified", "db_id": "1E28", "db_name": "PDB", "details": "NONSTANDARD PEPTIDE BINDING OF HLA-B*5101 COMPLEXED WITH HIV IMMUNODOMINANT EPITOPE KM2 (TAFTIPSI)"}, {"content_type": "unspecified", "db_id": "2VG7", "db_name": "PDB", "details": "CRYSTAL STRUCTURES OF HIV-1 REVERSE TRANSCRIPTASE COMPLEXES WITH THIOCARBAMATE NON- NUCLEOSIDE INHIBITORS"}, {"content_type": "unspecified", "db_id": "2BVP", "db_name": "PDB", "details": "STRUCTURES OF THREE HIV-1 HLA-B5703- PEPTIDE COMPLEXES AND IDENTIFICATION OF RELATED HLAS POTENTIALLY ASSOCIATED WITH LONG -TERM NON-PROGRESSION"}, {"content_type": "unspecified", "db_id": "1AJV", "db_name": "PDB", "details": "HIV-1 PROTEASE IN COMPLEX WITH THE CYCLIC SULFAMIDE INHIBITOR AHA006"}, {"content_type": "unspecified", "db_id": "1HAR", "db_name": "PDB", "details": "HIV-1 REVERSE TRANSCRIPTASE (AMINO-TERMINAL HALF) (FINGERS AND PALM SUBDOMAINS) (RT216)"}, {"content_type": "unspecified", "db_id": "1XR9", "db_name": "PDB", "details": "CRYSTAL STRUCTURES OF HLA-B*1501 IN COMPLEX WITH PEPTIDESFROM HUMAN UBCH6 AND EPSTEIN-BARR VIRUS EBNA-3"}, {"content_type": "unspecified", "db_id": "2V2X", "db_name": "PDB", "details": "T CELL CROSS-REACTIVITY AND CONFORMATIONAL CHANGES DURING TCR ENGAGEMENT."}, {"content_type": "unspecified", "db_id": "2GJ6", "db_name": "PDB", "details": "THE COMPLEX BETWEEN TCR A6 AND HUMAN CLASS I MHC HLA-A2WITH THE MODIFIED HTLV-1 TAX (Y5K-4-[3-INDOLYL]-BUTYRICACID) PEPTIDE"}, {"content_type": "unspecified", "db_id": "1D4J", "db_name": "PDB", "details": "HIV-1 PROTEASE IN COMPLEX WITH THE INHIBITOR MSL370"}, {"content_type": "unspecified", "db_id": "1QLF", "db_name": "PDB", "details": "MHC CLASS I H-2DB COMPLEXED WITH GLYCOPEPTIDE K3G"}, {"content_type": "unspecified", "db_id": "1EFX", "db_name": "PDB", "details": "STRUCTURE OF A COMPLEX BETWEEN THE HUMAN NATURAL KILLER CELL RECEPTOR KIR2DL2 AND A CLASS I MHC LIGAND HLA-CW3"}, {"content_type": "unspecified", "db_id": "2AV1", "db_name": "PDB", "details": "CRYSTAL STRUCTURE OF HTLV-1 TAX PEPTIDE BOUND TO HUMANCLASS I MHC HLA-A2 WITH THE E63Q AND K66A MUTATIONS IN THEHEAVY CHAIN."}, {"content_type": "unspecified", "db_id": "1TMC", "db_name": "PDB", "details": "TRUNCATED HUMAN CLASS I HISTOCOMPATIBILITY ANTIGEN HLA-AW68 COMPLEXED WITH A DECAMERIC PEPTIDE (EVAPPEYHRK)"}, {"content_type": "unspecified", "db_id": "1HQE", "db_name": "PDB", "details": "HUMAN IMMUNODEFICIENCY VIRUS TYPE 1"}, {"content_type": "unspecified", "db_id": "1QSF", "db_name": "PDB", "details": "STRUCTURE OF A6-TCR BOUND TO HLA-A2 COMPLEXED WITH ALTERED HTLV-1 TAX PEPTIDE Y8A"}, {"content_type": "unspecified", "db_id": "1AJX", "db_name": "PDB", "details": "HIV-1 PROTEASE IN COMPLEX WITH THE CYCLIC UREA INHIBITOR AHA001"}, {"content_type": "unspecified", "db_id": "1DUY", "db_name": "PDB", "details": "CRYSTAL STRUCTURE OF HLA-A0201/OCTAMERIC TAX PEPTIDE COMPLEX"}, {"content_type": "unspecified", "db_id": "1JGE", "db_name": "PDB", "details": "HLA-B*2705 BOUND TO NONA-PEPTIDE M9"}, {"content_type": "unspecified", "db_id": "1KPR", "db_name": "PDB", "details": "THE HUMAN NON-CLASSICAL MAJOR HISTOCOMPATIBILITY COMPLEXMOLECULE HLA-E"}, {"content_type": "unspecified", "db_id": "1S6P", "db_name": "PDB", "details": "CRYSTAL STRUCTURE OF HUMAN IMMUNODEFICIENCY VIRUS TYPE 1REVERSE TRANSCRIPTASE (RT) IN COMPLEX WITH JANSSEN-R100943"}, {"content_type": "unspecified", "db_id": "1IKV", "db_name": "PDB", "details": "K103N MUTANT HIV-1 REVERSE TRANSCRIPTASE IN COMPLEX WITHEFIVARENZ"}, {"content_type": "unspecified", "db_id": "1BQM", "db_name": "PDB", "details": "HIV-1 RT/HBY 097"}, {"content_type": "unspecified", "db_id": "2HJL", "db_name": "PDB", "details": "CRYSTAL STRUCTURE OF HLA-B5703 AND HIV-1 PEPTIDE"}, {"content_type": "unspecified", "db_id": "1QEW", "db_name": "PDB", "details": "HUMAN CLASS I HISTOCOMPATIBILITY ANTIGEN (HLA -A 0201)COMPLEX WITH A NONAMERIC PEPTIDE FROM MELANOMA-ASSOCIATEDANTIGEN 3 (RESIDUES 271-279)"}, {"content_type": "unspecified", "db_id": "1EC0", "db_name": "PDB", "details": "HIV-1 PROTEASE IN COMPLEX WITH THE INHIBITOR BEA403"}, {"content_type": "unspecified", "db_id": "1W0V", "db_name": "PDB", "details": "CRYSTAL STRUCTURE OF HLA-B*2705 COMPLEXED WITH THE SELF-PEPTIDE TIS FROM EGF- RESPONSE FACTOR 1"}, {"content_type": "unspecified", "db_id": "1K5N", "db_name": "PDB", "details": "HLA-B*2709 BOUND TO NONA-PEPTIDE M9"}, {"content_type": "unspecified", "db_id": "1RVQ", "db_name": "PDB", "details": "REVERSE TRANSCRIPTASE NON-NUCLEOSIDE BINDING SITE COMPLEXED WITH TIBO (THEORETICAL MODEL)"}, {"content_type": "unspecified", "db_id": "1AO7", "db_name": "PDB", "details": "COMPLEX BETWEEN HUMAN T-CELL RECEPTOR, VIRAL PEPTIDE (TAX), AND HLA-A 0201"}, {"content_type": "unspecified", "db_id": "2BNR", "db_name": "PDB", "details": "STRUCTURAL AND KINETIC BASIS FOR HIGHTENED IMMUNOGENICITY OF T CELL VACCINES"}, {"content_type": "unspecified", "db_id": "1XH3", "db_name": "PDB", "details": "CONFORMATIONAL RESTRAINTS AND FLEXIBILITY OF 14-MERICPEPTIDES IN COMPLEX WITH HLA-B* 3501"}, {"content_type": "unspecified", "db_id": "2BE2", "db_name": "PDB", "details": "CRYSTAL STRUCTURE OF HIV-1 REVERSE TRANSCRIPTASE (RT) INCOMPLEX WITH R221239"}, {"content_type": "unspecified", "db_id": "1S9G", "db_name": "PDB", "details": "CRYSTAL STRUCTURE OF HIV-1 REVERSE TRANSCRIPTASE (RT) INCOMPLEX WITH JANSSEN- R120394."}, {"content_type": "unspecified", "db_id": "2BST", "db_name": "PDB", "details": "CRYSTAL STRUCTURES AND KIR3DL1 RECOGNITION OF THREE IMMUNODOMINANT VIRAL PEPTIDES COMPLEXED TO HLA-B2705"}, {"content_type": "unspecified", "db_id": "1MI5", "db_name": "PDB", "details": "THE CRYSTAL STRUCTURE OF LC13 TCR IN COMPLEX WITH HLAB8-EBVPEPTIDE COMPLEX"}, {"content_type": "unspecified", "db_id": "1IKX", "db_name": "PDB", "details": "K103N MUTANT HIV-1 REVERSE TRANSCRIPTASE IN COMPLEX WITHTHE INHIBITOR PNU142721"}, {"content_type": "unspecified", "db_id": "1W5W", "db_name": "PDB", "details": "HIV-1 PROTEASE IN COMPLEX WITH FLUORO SUBSTITUTED DIOL-BASED C2-SYMMETRIC INHIBITOR"}, {"content_type": "unspecified", "db_id": "1IKY", "db_name": "PDB", "details": "HIV-1 REVERSE TRANSCRIPTASE IN COMPLEX WITH THE INHIBITORMSC194"}, {"content_type": "unspecified", "db_id": "1QMC", "db_name": "PDB", "details": "C-TERMINAL DNA-BINDING DOMAIN OF HIV-1 INTEGRASE, NMR, 42 STRUCTURES"}, {"content_type": "unspecified", "db_id": "2H26", "db_name": "PDB", "details": "HUMAN CD1B IN COMPLEX WITH ENDOGENOUS PHOSPHATIDYLCHOLINEAND SPACER"}, {"content_type": "unspecified", "db_id": "1EC2", "db_name": "PDB", "details": "HIV-1 PROTEASE IN COMPLEX WITH THE INHIBITOR BEA428"}, {"content_type": "unspecified", "db_id": "1A1O", "db_name": "PDB", "details": "MHC CLASS I MOLECULE B5301 COMPLEXED WITH PEPTIDE LS6 (KPIVQYDNF) FROM THE MALARIA PARASITE P. FALCIPARUM"}, {"content_type": "unspecified", "db_id": "1S9Y", "db_name": "PDB", "details": "CRYSTAL STRUCTURE ANALYSIS OF NY-ESO-1 EPITOPE ANALOGUE,SLLMWITQS, IN COMPLEX WITH HLA-A2"}, {"content_type": "unspecified", "db_id": "2A83", "db_name": "PDB", "details": "CRYSTAL STRUCTURE OF HLA-B*2705 COMPLEXED WITH THE GLUCAGONRECEPTOR (GR) PEPTIDE ( RESIDUES 412-420)"}, {"content_type": "unspecified", "db_id": "1AGF", "db_name": "PDB", "details": "ANTAGONIST HIV-1 GAG PEPTIDES INDUCE STRUCTURAL CHANGES IN HLA B8 - HIV-1 GAG PEPTIDE (GGKKRYKL - 5R MUTATION)"}, {"content_type": "unspecified", "db_id": "1OGA", "db_name": "PDB", "details": "A STRUCTURAL BASIS FOR IMMUNODOMINANT HUMAN T-CELL RECEPTOR RECOGNITION."}, {"content_type": "unspecified", "db_id": "1SV5", "db_name": "PDB", "details": "CRYSTAL STRUCTURE OF K103N MUTANT HIV-1 REVERSETRANSCRIPTASE (RT) IN COMPLEX WITH JANSSEN-R165335"}, {"content_type": "unspecified", "db_id": "2UY0", "db_name": "PDB", "details": "TWO-CARBON-ELONGATED HIV-1 PROTEASE INHIBITORS WITH A TERTIARY-ALCOHOL-CONTAINING TRANSITION-STATE MIMIC"}, {"content_type": "unspecified", "db_id": "1HMV", "db_name": "PDB", "details": "HIV-1 REVERSE TRANSCRIPTASE"}, {"content_type": "unspecified", "db_id": "2F8O", "db_name": "PDB", "details": "A NATIVE TO AMYLOIDOGENIC TRANSITION REGULATED BY ABACKBONE TRIGGER"}, {"content_type": "unspecified", "db_id": "2CII", "db_name": "PDB", "details": "THE CRYSTAL STRUCTURE OF H-2DB COMPLEXED WITH A PARTIAL PEPTIDE EPITOPE SUGGESTS AN MHC CLASS I ASSEMBLY-INTERMEDIATE"}, {"content_type": "unspecified", "db_id": "1I7R", "db_name": "PDB", "details": "CRYSTAL STRUCTURE OF CLASS I MHC A2 IN COMPLEX WITH PEPTIDEP1058"}, {"content_type": "unspecified", "db_id": "1JF1", "db_name": "PDB", "details": "CRYSTAL STRUCTURE OF HLA-A2*0201 IN COMPLEX WITH ADECAMERIC ALTERED PEPTIDE LIGAND FROM THE MART-1/MELAN-A"}, {"content_type": "unspecified", "db_id": "1S9E", "db_name": "PDB", "details": "CRYSTAL STRUCTURE OF HIV-1 REVERSE TRANSCRIPTASE (RT) INCOMPLEX WITH JANSSEN- R129385"}, {"content_type": "unspecified", "db_id": "2C7U", "db_name": "PDB", "details": "CONFLICTING SELECTIVE FORCES AFFECT CD8 T- CELL RECEPTOR CONTACT SITES IN AN HLA-A2 IMMUNODOMINANT HIV EPITOPE."}, {"content_type": "unspecified", "db_id": "1N5Y", "db_name": "PDB", "details": "HIV-1 REVERSE TRANSCRIPTASE CROSSLINKED TO POST-TRANSLOCATION AZTMP-TERMINATED DNA ( COMPLEX P)"}, {"content_type": "unspecified", "db_id": "2F74", "db_name": "PDB", "details": "MURINE MHC CLASS I H-2DB IN COMPLEX WITH HUMAN B2-MICROGLOBULIN AND LCMV-DERIVED IMMUNODMINANT PEPTIDE GP33"}, {"content_type": "unspecified", "db_id": "1E27", "db_name": "PDB", "details": "NONSTANDARD PEPTIDE BINDING OF HLA-B*5101 COMPLEXED WITH HIV IMMUNODOMINANT EPITOPE KM1 (LPPVVAKEI)"}, {"content_type": "unspecified", "db_id": "1W0W", "db_name": "PDB", "details": "CRYSTAL STRUCTURE OF HLA-B*2709 COMPLEXED WITH THE SELF-PEPTIDE TIS FROM EGF- RESPONSE FACTOR 1"}, {"content_type": "unspecified", "db_id": "1RVP", "db_name": "PDB", "details": "REVERSE TRANSCRIPTASE NON-NUCLEOSIDE BINDING SITE COMPLEXED WITH THIAZOLOISOINDOLINONE ( THEORETICAL MODEL)"}, {"content_type": "unspecified", "db_id": "1EET", "db_name": "PDB", "details": "HIV-1 REVERSE TRANSCRIPTASE IN COMPLEX WITH THE INHIBITOR MSC204"}, {"content_type": "unspecified", "db_id": "1GZQ", "db_name": "PDB", "details": "CD1B IN COMPLEX WITH PHOPHATIDYLINOSITOL"}, {"content_type": "unspecified", "db_id": "1UXS", "db_name": "PDB", "details": "CRYSTAL STRUCTURE OF HLA-B*2705 COMPLEXED WITH THE LATENT MEMBRANE PROTEIN 2 PEPTIDE (LMP2)OF EPSTEIN-BARR VIRUS"}, {"content_type": "unspecified", "db_id": "1W5X", "db_name": "PDB", "details": "HIV-1 PROTEASE IN COMPLEX WITH FLUORO SUBSTITUTED DIOL-BASED C2-SYMMETRIC INHIBITOR"}, {"content_type": "unspecified", "db_id": "2B6A", "db_name": "PDB", "details": "CRYSTAL STRUCTURE OF HIV-1 REVERSE TRANSCRIPTASE (RT) INCOMPLEX WITH THR-50"}, {"content_type": "unspecified", "db_id": "1AKJ", "db_name": "PDB", "details": "COMPLEX OF THE HUMAN MHC CLASS I GLYCOPROTEIN HLA-A2 ANDTHE T CELL CORECEPTOR CD8"}, {"content_type": "unspecified", "db_id": "1HVU", "db_name": "PDB", "details": "HUMAN IMMUNODEFICIENCY VIRUS TYPE 1 REVERSE TRANSCRIPTASE COMPLEXED WITH A 33-BASE NUCLEOTIDE RIBONUCLEIC ACID PSEUDOKNOT"}, {"content_type": "unspecified", "db_id": "2HJK", "db_name": "PDB", "details": "CRYSTAL STRUCTURE OF HLA-B5703 AND HIV-1 PEPTIDE"}, {"content_type": "unspecified", "db_id": "2VB5", "db_name": "PDB", "details": "SOLUTION STRUCTURE OF W60G MUTANT OF HUMAN BETA2-MICROGLOBULIN"}, {"content_type": "unspecified", "db_id": "1EBW", "db_name": "PDB", "details": "HIV-1 PROTEASE IN COMPLEX WITH THE INHIBITOR BEA322"}, {"content_type": "unspecified", "db_id": "1R3H", "db_name": "PDB", "details": "CRYSTAL STRUCTURE OF T10"}, {"content_type": "unspecified", "db_id": "1AGD", "db_name": "PDB", "details": "ANTAGONIST HIV-1 GAG PEPTIDES INDUCE STRUCTURAL CHANGES IN HLA B8 - HIV-1 GAG PEPTIDE (GGKKKYKL - INDEX PEPTIDE)"}, {"content_type": "unspecified", "db_id": "1EEY", "db_name": "PDB", "details": "CRYSTAL STRUCTURE DETERMINATION OF HLA A2 COMPLEXED TOPEPTIDE GP2 WITH THE SUBSTITUTION (I2L/V5L/L9V)"}, {"content_type": "unspecified", "db_id": "1I7T", "db_name": "PDB", "details": "CRYSTAL STRUCTURE OF CLASS I MHC A2 IN COMPLEX WITH PEPTIDEP1049-5V"}, {"content_type": "unspecified", "db_id": "1I4F", "db_name": "PDB", "details": "CRYSTAL STRUCTURE OF HLA-A*0201/MAGE-A4- PEPTIDE COMPLEX"}, {"content_type": "unspecified", "db_id": "1YDP", "db_name": "PDB", "details": "1.9A CRYSTAL STRUCTURE OF HLA-G"}, {"content_type": "unspecified", "db_id": "1EBY", "db_name": "PDB", "details": "HIV-1 PROTEASE IN COMPLEX WITH THE INHIBITOR BEA369"}, {"content_type": "unspecified", "db_id": "1J5O", "db_name": "PDB", "details": "CRYSTAL STRUCTURE OF MET184ILE MUTANT OF HIV -1 REVERSETRANSCRIPTASE IN COMPLEX WITH DOUBLE STRANDED DNA TEMPLATE-PRIMER"}, {"content_type": "unspecified", "db_id": "1HVP", "db_name": "PDB", "details": "HIV-1 PROTEASE COMPLEX WITH SUBSTRATE ( THEORETICAL MODEL)"}, {"content_type": "unspecified", "db_id": "1MES", "db_name": "PDB", "details": "HIV-1 MUTANT (I84V) PROTEASE COMPLEXED WITH DMP323"}, {"content_type": "unspecified", "db_id": "2VLL", "db_name": "PDB", "details": "THE STRUCTURAL DYNAMICS AND ENERGETICS OF AN IMMUNODOMINANT T-CELL RECEPTOR ARE PROGRAMMED BY ITS VBETA DOMAIN"}, {"content_type": "unspecified", "db_id": "1EC3", "db_name": "PDB", "details": "HIV-1 PROTEASE IN COMPLEX WITH THE INHIBITOR MSA367"}, {"content_type": "unspecified", "db_id": "2BSR", "db_name": "PDB", "details": "CRYSTAL STRUCTURES AND KIR3DL1 RECOGNITION OF THREE IMMUNODOMINANT VIRAL PEPTIDES COMPLEXED TO HLA-B2705"}, {"content_type": "unspecified", "db_id": "2VLJ", "db_name": "PDB", "details": "THE STRUCTURAL DYNAMICS AND ENERGETICS OF AN IMMUNODOMINANT T-CELL RECEPTOR ARE PROGRAMMED BY ITS VBETA DOMAIN"}, {"content_type": "unspecified", "db_id": "1B0R", "db_name": "PDB", "details": "CRYSTAL STRUCTURE OF HLA-A0201 COMPLEXED WITH A PEPTIDE WITH THE CARBOXYL-TERMINAL GROUP SUBSTITUTED BY A METHYL GROUP"}, {"content_type": "unspecified", "db_id": "1B0G", "db_name": "PDB", "details": "CRYSTAL STRUCTURE OF HUMAN CLASS I MHC ( HLA-A2.1) COMPLEXED WITH BETA 2- MICROGLOBULIN AND HUMAN PEPTIDE P1049"}, {"content_type": "unspecified", "db_id": "1OF2", "db_name": "PDB", "details": "CRYSTAL STRUCTURE OF HLA-B*2709 COMPLEXED WITH THE VASOACTIVE INTESTINAL PEPTIDE TYPE 1 RECEPTOR (VPAC1) PEPTIDE (RESIDUES 400-408)"}, {"content_type": "unspecified", "db_id": "1HHI", "db_name": "PDB"}, {"content_type": "unspecified", "db_id": "1QSE", "db_name": "PDB", "details": "STRUCTURE OF HUMAN A6-TCR BOUND TO HLA- A2 COMPLEXED WITH ALTERED HTLV-1 TAX PEPTIDE V7R"}, {"content_type": "unspecified", "db_id": "2AXG", "db_name": "PDB", "details": "THE IMMUNOGENICITY OF A VIRAL CYTOTOXIC T CELL EPITOPE ISCONTROLLED BY ITS MHC-BOUND CONFORMATION"}, {"content_type": "unspecified", "db_id": "1A9B", "db_name": "PDB", "details": "DECAMER-LIKE CONFORMATION OF A NANO-PEPTIDE BOUND TO HLA-B 3501 DUE TO NONSTANDARD POSITIONING OF THE C-TERMINUS"}, {"content_type": "unspecified", "db_id": "1AGC", "db_name": "PDB", "details": "ANTAGONIST HIV-1 GAG PEPTIDES INDUCE STRUCTURAL CHANGES IN HLA B8 - HIV-1 GAG PEPTIDE (GGKKKYQL - 7Q MUTATION)"}, {"content_type": "unspecified", "db_id": "2BVQ", "db_name": "PDB", "details": "STRUCTURES OF THREE HIV-1 HLA-B5703- PEPTIDE COMPLEXES AND IDENTIFICATION OF RELATED HLAS POTENTIALLY ASSOCIATED WITH LONG -TERM NON-PROGRESSION"}, {"content_type": "unspecified", "db_id": "1HHJ", "db_name": "PDB", "details": "HUMAN CLASS I HISTOCOMPATIBILITY ANTIGEN (HLA -A 0201) COMPLEX WITH A NONAMERIC PEPTIDE FROM HIV-1 REVERSE TRANSCRIPTASE (RESIDUES 309-317)"}, {"content_type": "unspecified", "db_id": "1QVO", "db_name": "PDB", "details": "STRUCTURES OF HLA-A*1101 IN COMPLEX WITH IMMUNODOMINANTNONAMER AND DECAMER HIV-1 EPITOPES CLEARLY REVEAL THEPRESENCE OF A MIDDLE ANCHOR RESIDUE"}, {"content_type": "unspecified", "db_id": "1S9W", "db_name": "PDB", "details": "CRYSTAL STRUCTURE ANALYSIS OF NY-ESO-1 EPITOPE, SLLMWITQC,IN COMPLEX WITH HLA-A2"}, {"content_type": "unspecified", "db_id": "1KTL", "db_name": "PDB", "details": "THE HUMAN NON-CLASSICAL MAJOR HISTOCOMPATIBILITY COMPLEXMOLECULE HLA-E"}, {"content_type": "unspecified", "db_id": "1BQN", "db_name": "PDB", "details": "TYR 188 LEU HIV-1 RT/HBY 097"}, {"content_type": "unspecified", "db_id": "1A6Z", "db_name": "PDB", "details": "HFE (HUMAN) HEMOCHROMATOSIS PROTEIN"}, {"content_type": "unspecified", "db_id": "2VG5", "db_name": "PDB", "details": "CRYSTAL STRUCTURES OF HIV-1 REVERSE TRANSCRIPTASE COMPLEXES WITH THIOCARBAMATE NON- NUCLEOSIDE INHIBITORS"}, {"content_type": "unspecified", "db_id": "1RVM", "db_name": "PDB", "details": "REVERSE TRANSCRIPTASE NON-NUCLEOSIDE BINDING SITE COMPLEXED WITH HEPT (THEORETICAL MODEL)"}, {"content_type": "unspecified", "db_id": "2CIK", "db_name": "PDB", "details": "INSIGHTS INTO CROSSREACTIVITY IN HUMAN ALLORECOGNITION: THE STRUCTURE OF HLA-B35011 PRESENTING AN EPITOPE DERIVED FROM CYTOCHROME P450."}, {"content_type": "unspecified", "db_id": "1NPV", "db_name": "PDB", "details": "CRYSTAL STRUCTURE OF HIV-1 PROTEASE COMPLEXED WITH LDC271"}, {"content_type": "unspecified", "db_id": "2UWE", "db_name": "PDB", "details": "LARGE CDR3A LOOP ALTERATION AS A FUNCTION OF MHC MUTATION"}, {"content_type": "unspecified", "db_id": "1I1F", "db_name": "PDB", "details": "CRYSTAL STRUCTURE OF HUMAN CLASS I MHC ( HLA-A2.1) COMPLEXED WITH BETA 2- MICROGLOBULIN AND HIV-RT VARIANT PEPTIDE I1Y"}, {"content_type": "unspecified", "db_id": "2AV7", "db_name": "PDB", "details": "CRYSTAL STRUCTURE OF HTLV-1 TAX PEPTIDE BOUND TO HUMANCLASS I MHC HLA-A2 WITH THE K66A MUTATION IN THE HEAVYCHAIN."}, {"content_type": "unspecified", "db_id": "2X4P", "db_name": "PDB", "details": "CRYSTAL STRUCTURE OF MHC CLASS I HLA-A2. 1 BOUND TO A PHOTOCLEAVABLE PEPTIDE"}, {"content_type": "unspecified", "db_id": "2X4S", "db_name": "PDB", "details": "CRYSTAL STRUCTURE OF MHC CLASS I HLA-A2. 1 BOUND TO A PEPTIDE REPRESENTING THE EPITOPE OF THE H5N1 (AVIAN FLU) NUCLEOPROTEIN"}, {"content_type": "unspecified", "db_id": "2X4T", "db_name": "PDB", "details": "CRYSTAL STRUCTURE OF MHC CLASS I HLA-A2. 1 BOUND TO A PEIODATE-CLEAVABLE PEPTIDE"}, {"content_type": "unspecified", "db_id": "2X4N", "db_name": "PDB", "details": "CRYSTAL STRUCTURE OF MHC CLASS I HLA-A2. 1 BOUND TO RESIDUAL FRAGMENTS OF A PHOTOCLEAVABLE PEPTIDE THAT IS CLEAVED UPON UV-LIGHT TREATMENT"}, {"content_type": "unspecified", "db_id": "2X4M", "db_name": "PDB", "details": "CRYSTAL STRUCTURE OF MHC CLASS I HLA-A2. 1 BOUND TO A PHOTOCLEAVABLE PEPTIDE"}, {"content_type": "unspecified", "db_id": "2X4O", "db_name": "PDB", "details": "CRYSTAL STRUCTURE OF MHC CLASS I HLA-A2. 1 BOUND TO HIV-1 ENVELOPE PEPTIDE ENV120- 128"}, {"content_type": "unspecified", "db_id": "2X4R", "db_name": "PDB", "details": "CRYSTAL STRUCTURE OF MHC CLASS I HLA-A2. 1 BOUND TO CYTOMEGALOVIRUS (CMV) PP65 EPITOPE"}, {"content_type": "unspecified", "db_id": "2X4Q", "db_name": "PDB", "details": "CRYSTAL STRUCTURE OF MHC CLASS I HLA-A2. 1 BOUND TO A PHOTOCLEAVABLE PEPTIDE"}], "pdbx_database_status": {"deposit_site": "PDBE", "pdb_format_compatible": "Y", "process_site": "PDBE", "recvd_initial_deposition_date": "2010-02-02T00:00:00+0000", "status_code": "REL", "status_code_sf": "REL"}, "pdbx_vrpt_summary": {"babinet_b": 83.459, "babinet_k": 0.198, "fo_fc_correlation": 0.956, "wilson_baniso": "[32.564,37.850,29.399,0.000,0.623,0.000]", "wilson_bestimate": 33.002, "absolute_percentile_dccrfree": 58.0, "absolute_percentile_clashscore": 30.9, "absolute_percentile_percent_rsrzoutliers": 30.2, "absolute_percentile_percent_ramachandran_outliers": 51.4, "absolute_percentile_percent_rotamer_outliers": 43.1, "acentric_outliers": 0, "angles_rmsz": 0.46, "attempted_validation_steps": "molprobity,validation-pack,xtriage,eds,mogul,buster-report,percentiles,writexml", "bonds_rmsz": 0.26, "bulk_solvent_b": 51.087, "bulk_solvent_k": 0.348, "ccp4version": "7.0.044 (Gargrove)", "centric_outliers": 0.0, "clashscore": 9.06, "data_anisotropy": 0.254, "data_completeness": 97.2, "high_resol_relative_percentile_dccrfree": 2.1, "high_resol_relative_percentile_clashscore": 2.1, "high_resol_relative_percentile_percent_rsrzoutliers": 2.1, "high_resol_relative_percentile_percent_ramachandran_outliers": 2.1, "high_resol_relative_percentile_percent_rotamer_outliers": 2.1, "low_resol_relative_percentile_dccrfree": 2.1, "low_resol_relative_percentile_clashscore": 2.1, "low_resol_relative_percentile_percent_rsrzoutliers": 2.1, "low_resol_relative_percentile_percent_ramachandran_outliers": 2.1, "low_resol_relative_percentile_percent_rotamer_outliers": 2.1, "no_ligands_for_buster_report": "yes", "num_hreduce": 6318.0, "num_pdbids_absolute_percentile_dccrfree": 130704, "num_pdbids_absolute_percentile_clashscore": 141614, "num_pdbids_absolute_percentile_percent_rsrzoutliers": 127900, "num_pdbids_absolute_percentile_percent_ramachandran_outliers": 138981, "num_pdbids_absolute_percentile_percent_rotamer_outliers": 138945, "num_pdbids_relative_percentile_dccrfree": 5197, "num_pdbids_relative_percentile_clashscore": 5710, "num_pdbids_relative_percentile_percent_rsrzoutliers": 5083, "num_pdbids_relative_percentile_percent_ramachandran_outliers": 5647, "num_pdbids_relative_percentile_percent_rotamer_outliers": 5648, "num_angles_rmsz": 9097, "num_bonds_rmsz": 6726, "num_free_reflections": 2336, "num_miller_indices": 45967, "percent_rsrzoutliers": 4.82, "percent_free_reflections": 5.08, "percent_ramachandran_outliers": 0.13, "percent_rotamer_outliers": 2.84, "percentilebins": ["all", "2.1", "xray"], "protein_dnarnaentities": "1,2,3", "refmac_version": "5.8.0158", "relative_percentile_dccrfree": 67.2, "relative_percentile_clashscore": 30.8, "relative_percentile_percent_rsrzoutliers": 35.6, "relative_percentile_percent_ramachandran_outliers": 53.8, "relative_percentile_percent_rotamer_outliers": 47.0, "report_creation_date": "Jun 14, 2020 -- 06:16 pm BST", "restypes_notchecked_for_bond_angle_geometry": ["GOL", "MES"], "trans_nsc": "The largest off-origin peak in the Patterson function is 5.20% of the height of the origin peak. No significant pseudotranslation is detected.", "twin_l": 0.481, "twin_l2": 0.311, "twin_fraction": "-h,-l,-k:0.021;-h,l,k:0.008;h,-k,-l:0.060", "xtriage_input_columns": "F_meas_au,F_meas_sigma_au", "bfactor_type": "FULL", "dccr": 0.18, "dccrfree": 0.23, "dccrefinement_program": "PHENIX", "edsr": 0.19, "edsresolution": 2.1, "edsresolution_low": 19.94, "iover_sigma": "3.96(2.09A)", "pdbr": 0.18, "pdbrfree": 0.23, "pdbdeposition_date": "2010-02-02T00:00:00+0000", "pdbresolution": 2.1, "pdbresolution_low": 19.95, "pdbrevision_date": "2019-10-16T00:00:00+0000", "pdbrevision_number": 4.0}, "rcsb_accession_info": {"deposit_date": "2010-02-02T00:00:00+0000", "has_released_experimental_data": "Y", "initial_release_date": "2010-03-02T00:00:00+0000", "major_revision": 1, "minor_revision": 3, "revision_date": "2019-10-16T00:00:00+0000", "status_code": "REL"}, "rcsb_entry_container_identifiers": {"assembly_ids": ["1", "2"], "entity_ids": ["1", "2", "3", "4", "5", "6"], "entry_id": "2X4U", "model_ids": [1], "non_polymer_entity_ids": ["4", "5"], "polymer_entity_ids": ["1", "2", "3"], "rcsb_id": "2X4U", "pubmed_id": 19655750}, "rcsb_entry_info": {"assembly_count": 2, "branched_entity_count": 0, "cis_peptide_count": 7, "deposited_atom_count": 7087, "deposited_hydrogen_atom_count": 0, "deposited_model_count": 1, "deposited_modeled_polymer_monomer_count": 768, "deposited_nonpolymer_entity_instance_count": 14, "deposited_polymer_entity_instance_count": 6, "deposited_polymer_monomer_count": 768, "deposited_solvent_atom_count": 425, "deposited_unmodeled_polymer_monomer_count": 0, "diffrn_radiation_wavelength_maximum": 0.9793, "diffrn_radiation_wavelength_minimum": 0.9793, "disulfide_bond_count": 6, "entity_count": 6, "experimental_method": "X-ray", "experimental_method_count": 1, "inter_mol_covalent_bond_count": 0, "inter_mol_metalic_bond_count": 0, "molecular_weight": 91.26, "na_polymer_entity_types": "Other", "nonpolymer_entity_count": 2, "nonpolymer_molecular_weight_maximum": 0.2, "nonpolymer_molecular_weight_minimum": 0.09, "polymer_composition": "heteromeric protein", "polymer_entity_count": 3, "polymer_entity_count_dna": 0, "polymer_entity_count_rna": 0, "polymer_entity_count_nucleic_acid": 0, "polymer_entity_count_nucleic_acid_hybrid": 0, "polymer_entity_count_protein": 3, "polymer_entity_taxonomy_count": 3, "polymer_molecular_weight_maximum": 31.85, "polymer_molecular_weight_minimum": 0.99, "polymer_monomer_count_maximum": 275, "polymer_monomer_count_minimum": 9, "resolution_combined": [2.1], "selected_polymer_entity_types": "Protein (only)", "software_programs_combined": ["AMORE", "MOSFLM", "PHENIX", "TRUNCATE"], "solvent_entity_count": 1, "diffrn_resolution_high": {"provenance_source": "Depositor assigned", "value": 2.1}}, "rcsb_primary_citation": {"country": "US", "id": "primary", "journal_abbrev": "J.Am.Chem.Soc.", "journal_id_astm": "JACSAT", "journal_id_csd": "0004", "journal_id_issn": "0002-7863", "journal_volume": "131", "page_first": "12298", "pdbx_database_id_doi": "10.1021/JA9037559", "pdbx_database_id_pub_med": 19655750, "rcsb_orcididentifiers": ["?", "?", "?", "?", "?", "?"], "rcsb_authors": ["Celie, P.H.N.", "Toebes, M.", "Rodenko, B.", "Ovaa, H.", "Perrakis, A.", "Schumacher, T.N.M."], "rcsb_journal_abbrev": "J Am Chem Soc", "title": "Uv-Induced Ligand Exchange in Mhc Class I Protein Crystals.", "year": 2009}, "refine": [{"aniso_b11": -0.6252, "aniso_b12": 0.0, "aniso_b13": 0.6627, "aniso_b22": 4.3599, "aniso_b23": 0.0, "aniso_b33": -3.7346, "ls_rfactor_rfree": 0.234, "ls_rfactor_rwork": 0.1762, "ls_rfactor_obs": 0.1787, "ls_dres_high": 2.1, "ls_dres_low": 19.95, "ls_number_reflns_rfree": 1985, "ls_number_reflns_obs": 45960, "ls_percent_reflns_rfree": 4.3, "ls_percent_reflns_obs": 97.31, "overall_suml": 0.28, "pdbx_diffrn_id": ["1"], "pdbx_ls_sigma_f": 1.41, "pdbx_method_to_determine_struct": "MOLECULAR REPLACEMENT", "pdbx_overall_phase_error": 21.8, "pdbx_refine_id": "X-RAY DIFFRACTION", "pdbx_solvent_shrinkage_radii": 0.9, "pdbx_solvent_vdw_probe_radii": 1.11, "pdbx_starting_model": "PDB ENTRY 1EEY", "pdbx_stereochemistry_target_values": "ML", "solvent_model_details": "FLAT BULK SOLVENT MODEL", "solvent_model_param_bsol": 51.778, "solvent_model_param_ksol": 0.4, "biso_mean": 39.94}], "refine_hist": [{"cycle_id": "LAST", "number_atoms_solvent": 425, "number_atoms_total": 6847, "pdbx_number_atoms_ligand": 114, "pdbx_number_atoms_nucleic_acid": 0, "pdbx_number_atoms_protein": 6308, "pdbx_refine_id": "X-RAY DIFFRACTION", "dres_high": 2.1, "dres_low": 19.95}], "refine_ls_restr": [{"dev_ideal": 0.007, "number": 6862, "pdbx_refine_id": "X-RAY DIFFRACTION", "type": "f_bond_d"}, {"dev_ideal": 1.474, "number": 9310, "pdbx_refine_id": "X-RAY DIFFRACTION", "type": "f_angle_d"}, {"dev_ideal": 18.785, "number": 2537, "pdbx_refine_id": "X-RAY DIFFRACTION", "type": "f_dihedral_angle_d"}, {"dev_ideal": 0.165, "number": 929, "pdbx_refine_id": "X-RAY DIFFRACTION", "type": "f_chiral_restr"}, {"dev_ideal": 0.004, "number": 1224, "pdbx_refine_id": "X-RAY DIFFRACTION", "type": "f_plane_restr"}], "reflns": [{"number_obs": 46009, "observed_criterion_sigma_i": -3.7, "pdbx_rmerge_iobs": 0.05, "pdbx_diffrn_id": ["1"], "pdbx_net_iover_sigma_i": 8.4, "pdbx_ordinal": 1, "pdbx_redundancy": 3.8, "percent_possible_obs": 97.6, "biso_wilson_estimate": 33.03, "dresolution_high": 2.1, "dresolution_low": 50.0}], "reflns_shell": [{"rmerge_iobs": 0.2, "mean_iover_sig_iobs": 3.9, "pdbx_diffrn_id": ["1"], "pdbx_ordinal": 1, "pdbx_redundancy": 3.7, "percent_possible_all": 97.6, "dres_high": 2.1, "dres_low": 2.21}], "software": [{"classification": "refinement", "name": "PHENIX", "pdbx_ordinal": 1, "version": "(PHENIX.REFINE)"}, {"classification": "data reduction", "name": "MOSFLM", "pdbx_ordinal": 2}, {"classification": "data scaling", "name": "TRUNCATE", "pdbx_ordinal": 3}, {"classification": "phasing", "name": "AMoRE", "pdbx_ordinal": 4}], "struct": {"pdbx_descriptor": "HLA CLASS I HISTOCOMPATIBILITY ANTIGEN, A-2 ALPHA CHAIN, BETA-2-MICROGLOBULIN, REVERSE TRANSCRIPTASE/RIBONUCLEASE H (E.C.2.7.7.49, 2.7.7.7, 3.1.26.4)", "title": "Crystal structure of MHC CLass I HLA-A2.1 bound to HIV-1 Peptide RT468-476"}, "struct_keywords": {"pdbx_keywords": "IMMUNE SYSTEM", "text": "GLYCOPROTEIN, IMMUNE SYSTEM, TRANSMEMBRANE, PHOSPHOPROTEIN, IMMUNE RESPONSE, SECRETED, GLYCATION, AMYLOIDOSIS, IMMUNOGLOBULIN DOMAIN, HOST-VIRUS INTERACTION, AMYLOID, MEMBRANE, PHOTOCLEAVABLE PEPTIDE, PYRROLIDONE CARBOXYLIC ACID, ENVELOPE PROTEIN, DISEASE MUTATION"}, "symmetry": {"int_tables_number": 4, "space_group_name_hm": "P 1 21 1"}, "rcsb_id": "2X4U"}